Suchergebnisse - "Ofran, Yishai"

PubPharm (7)

1

Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia

enthalten in: European journal of haematology | 2023

von Canaani, J. | Frisch, A. | Pollyea, D. | +11

2

Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study

enthalten in: American journal of hematology | 2022

von Jonas, B. | DiNardo, C. | Fracchiolla, N. | +13

3

Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia

enthalten in: American journal of hematology | 2022

von Jonas, B. | Wei, A. | Recher, C. | +14

4

Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia : a real-world analysis

enthalten in: Annals of hematology | 2022

von Wolach, O. | Frisch, A. | Shargian, L. | +11

5

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

enthalten in: Blood cancer journal | 2022

von Pratz, K. | Panayiotidis, P. | Recher, C. | +23

6

Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice

enthalten in: American journal of hematology | 2021

von Apel, A. | Moshe, Y. | Ofran, Y. | +12

7

Venetoclax is safe and efficacious in relapsed/refractory AML

enthalten in: Leukemia & lymphoma | 2020

von Ganzel, C. | Ram, R. | Gural, A. | +16

1
[1]